The manufacturer must clearly state in the product manual that "for research use only, not for human treatment", and remind users to be aware of potential risks
The most common side effects are extremely mild and infrequent, primarily involving occasional skin irritation, mild redness, or transient tingling sensation in a small percentage of users, typically resolving without intervention and not requiring discontinuation
One study measured plasma 5-HT in FD and found decreased basal and postprandial plasma compared to health ( Several 5-HT receptor agonists/antagonists, such as cisapride (5-HT4 agonist, 5-HT2, and 5-HT3 antagonist), tegaserod (5-HT4 and 5-HT1 agonist, 5-HT2a/b antagonist), mosapride (5-HT4 agonist, 5-HT3 antagonist) and revexepride (5-HT4 agonist) have been evaluated for the treatment of dyspepsia and gastroparesis, although not all studies show efficacy (114116)
This means that every time you think you are using 1mg of Tirzepatide, you are only using 0.5mg, which can throw off your entire experiment
Nodules from BPC-157 resolve without treatment within two to three days